Feasibility of a deep learning algorithm to achieve the low-dose


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Sep 2023
Historique:
pmc-release: 01 09 2024
medline: 21 8 2023
pubmed: 2 7 2023
entrez: 2 7 2023
Statut: ppublish

Résumé

Our work aims to study the feasibility of a deep learning algorithm to reduce the The data of 130 patients who underwent Data showed that the DL-33% images of the two test data sets met the clinical diagnosis requirements, and the overall lesion detection rate of the two centers reached 95.9%. Through deep learning, we demonstrated that reducing the This is the first study of low-dose

Identifiants

pubmed: 37393527
doi: 10.1259/bjr.20230038
pmc: PMC10461288
doi:

Substances chimiques

Gallium Radioisotopes 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20230038

Références

EJNMMI Phys. 2018 Apr 18;5(1):9
pubmed: 29666972
Eur J Radiol. 2021 Sep;142:109867
pubmed: 34315086
EJNMMI Phys. 2022 May 11;9(1):36
pubmed: 35543894
Neurocomputing (Amst). 2017 Dec 6;267:406-416
pubmed: 29217875
Radiology. 2021 Feb;298(2):393-402
pubmed: 33258746
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3750-3760
pubmed: 35593925
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385
pubmed: 34137945
EJNMMI Res. 2017 Dec;7(1):3
pubmed: 28091978
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100
pubmed: 34050777
EJNMMI Res. 2020 Mar 23;10(1):27
pubmed: 32201912
J Nucl Med. 2021 Jan;62(1):123-130
pubmed: 32482791
Abdom Radiol (NY). 2023 Mar;48(3):895-901
pubmed: 36583752
Radiother Oncol. 2021 May;158:55-61
pubmed: 33621587
J Digit Imaging. 2019 Oct;32(5):773-778
pubmed: 30402670
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1178-1187
pubmed: 33057927
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2507-2515
pubmed: 32424483
J Nucl Cardiol. 2021 Jun;28(3):812-821
pubmed: 32975729
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3378-3385
pubmed: 33738519
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2405-2415
pubmed: 33495927
Radiology. 2020 Dec;297(3):521
pubmed: 33048036
Proteomics Clin Appl. 2014 Jun;8(5-6):454-63
pubmed: 24470260
J Nucl Med. 2019 Mar;60(3):299-303
pubmed: 30733314
Eur J Radiol. 2018 Sep;106:184-191
pubmed: 30150043
Phys Med Biol. 2019 Nov 04;64(21):215017
pubmed: 31561244
Ann Nucl Med. 2021 Dec;35(12):1321-1331
pubmed: 34436740
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Comput Methods Programs Biomed. 1995 Dec;48(3):257-62
pubmed: 8925653
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):743-750
pubmed: 34302504
EJNMMI Phys. 2022 Feb 4;9(1):7
pubmed: 35122172
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1915-1931
pubmed: 33244617

Auteurs

Lin Liu (L)

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China.
Institute of Nuclear Medicine, Southwest Medical University, Luzhou, China.

Xingyu Chen (X)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Chongqing University of Technology, Chongqing, China.

Liwen Wan (L)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Na Zhang (N)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, China.

Ruibao Hu (R)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Wenbo Li (W)

Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Shengping Liu (S)

Chongqing University of Technology, Chongqing, China.

Yan Zhu (Y)

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China.
Institute of Nuclear Medicine, Southwest Medical University, Luzhou, China.

Hua Pang (H)

Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Dong Liang (D)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Yue Chen (Y)

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China.
Institute of Nuclear Medicine, Southwest Medical University, Luzhou, China.

Zhanli Hu (Z)

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH